These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6278364)

  • 1. Abnormalities of cerebral oxidative metabolism in animal models of Parkinson disease.
    Harik SI; LaManna JC; Snyder S; Wetherbee JR; Rosenthal M
    Neurology; 1982 Apr; 32(4):382-9. PubMed ID: 6278364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine turnover and glutathione oxidation: implications for Parkinson disease.
    Spina MB; Cohen G
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1398-400. PubMed ID: 2919185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of cerebral oxidative metabolism with aging and their relation to the central noradrenergic system.
    Sylvia AL; Harik SI; LaManna JC; Wilkerson T; Rosenthal M
    Gerontology; 1983; 29(4):248-61. PubMed ID: 6307831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine depletion alters cerebral oxidative metabolism in the "active" state.
    LaManna JC; Harik SI; Light AI; Rosenthal M
    Brain Res; 1981 Jan; 204(1):87-101. PubMed ID: 6265026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
    Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
    Kress GJ; Reynolds IJ
    Neurobiol Dis; 2005 Dec; 20(3):639-45. PubMed ID: 15996475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo (1)H MRS study.
    Kickler N; Lacombe E; Chassain C; Durif F; Krainik A; Farion R; Provent P; Segebarth C; Rémy C; Savasta M
    NMR Biomed; 2009 Feb; 22(2):207-12. PubMed ID: 19130495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases.
    Goto S; Hirano A; Matsumoto S
    Ann Neurol; 1990 May; 27(5):520-7. PubMed ID: 1694418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyl radical production in the cortex and striatum in a rat model of focal cerebral ischemia.
    Ste-Marie L; Vachon P; Vachon L; Bémeur C; Guertin MC; Montgomery J
    Can J Neurol Sci; 2000 May; 27(2):152-9. PubMed ID: 10830350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T; Barroso-Chinea P; Rodríguez M
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental change on dopaminergic neurons in striatum of Parkinson disease rats.
    Chen XY; Li J; Qi WQ; Shen SH
    Histol Histopathol; 2007 Oct; 22(10):1085-90. PubMed ID: 17616935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
    Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
    Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
    Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.
    Tassorelli C; Armentero MT; Greco R; Fancellu R; Sandrini G; Nappi G; Blandini F
    Brain Res; 2007 Oct; 1176():53-61. PubMed ID: 17884026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.